trapidil has been researched along with Carcinoma, Hepatocellular in 1 studies
Trapidil: A coronary vasodilator agent.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beitz, J | 1 |
| Corsini, A | 1 |
| Granata, A | 1 |
| Fumagalli, R | 1 |
| Mest, HJ | 1 |
| Paoletti, R | 1 |
1 other study available for trapidil and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effect of derivatives of trapidil on the expression of LDL receptors.
Topics: Antihypertensive Agents; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Humans; Kinetics; Li | 1988 |